Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study
- PMID: 35401242
- PMCID: PMC8984177
- DOI: 10.3389/fphar.2022.811289
Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study
Abstract
Introduction: Performing pharmacist interventions (PIs) during the medication review helps to improve the quality of care. The acceptance by the physician of these PIs is a good indicator of the quality of this clinical pharmacy activity. The objective of this study was to determine, in the Amiens-Picardie teaching hospital (France), factors of acceptance in a variable environment of activity (central pharmacy, in the care units, computer assisted). Methods: All PIs transcribed by pharmacists on the Act-IP© site between November 2018 and April 2019 were analyzed using a complementary search in patient records. The environment, type, and clinical impact on patient health of each PI was collected. Linear mixed-effects models with a random pharmacist intercept were used to investigate the relationship between PI modalities and their chance of being accepted. Results: A total of 3,100 PIs were traced, of which 2,930 had been followed over time. Of these, 2,930 PIs, 1,504 (51.3%) were performed by a postgraduate pharmacist and 1,426 (48.7%) by a pharmacy resident, 1,623 (55.4%) were performed by verbal exchange, 455 (15.5%) by telephone, 846 (28.9%) by computer software, and 6 (0.2%) by paper. The clinical impact on patient health was major for 976 PIs (33.3%) and vital for 26 PIs (0.9%). According to the Anatomical Therapeutic Chemical Classification (ATC), they were mainly related to anti-infectives (30.3%), the nervous system (18.7%), and blood and blood-forming organs (17.3%). In total, 2,415 PIs (82.4%) were accepted. According to the multivariate model, a PI was more often accepted when it was transmitted orally rather than by software (+27.7%, 95% CI: +23.2 to +32.1%) and when it was transmitted to a medical resident rather than a postgraduate physician (+4.4%, 95% CI: 1.2-7.6%). In these cases, there was a major rather than a moderate clinical impact on patient health (+4.3%, 95% CI: +1.1-+7.6%). Conclusion: This study highlights the importance of the quality of the exchange with the prescriber and the prioritization of high-risk interventions as key points of medication review to improve rate of pharmacist interventions accepted by physician.
Keywords: clinical pharmacy; contact method; medication review; pharmacist interventions; quality of care.
Copyright © 2022 Durand, Gillibert, Membre, Mondet, Lenglet and Mary.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Allenet B., Baudrant-Boga M., Bedouch P., Calop J., Foroni L. (2009). Le pharmacien a-t-il une place au sein de l'unité de soins ? Expérience du centre hospitalier universitaire de Grenoble. Méd. des Mal. Métab. 3, 442–447. 10.1016/S1957-2557(09)72414-9 - DOI
-
- Allenet B., Juste M., Mouchoux C., Collomp R., Pourrat X., Varin R., et al. (2019). De la dispensation au plan pharmaceutique personnalisé: vers un modèle intégratif de pharmacie clinique. Le Pharma. Hosp. Clin. 54, 56–63. 10.1016/j.phclin.2018.12.003 - DOI
-
- Bedouch P., Sylvoz N., Charpiat B., Juste M., Roubille R., Rose F. X., et al. (2015). Trends in Pharmacists' Medication Order Review in French Hospitals from 2006 to 2009: Analysis of Pharmacists' Interventions from the Act-Ip© Website Observatory. J. Clin. Pharm. Ther. 40, 32–40. 10.1111/jcpt.12214 - DOI - PubMed
-
- Benoit P., Mangerel K., Garreau I., Vonna P., Juste M. (2007). Évaluation des moyens mis en œuvre et acceptation d’une présence pharmaceutique dans les services de soins. J. Pharm. Clin. 26, 83–90. 10.1684/jpc.2007.0054 - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous